about
Variation in diabetes care by age: opportunities for customization of careThe association between diabetes related medical costs and glycemic control: a retrospective analysis.The use of adherence aids by adults with diabetes: a cross-sectional surveyThe effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisPharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practiceEffectiveness of pharmacist-administered diabetes mellitus education and management servicesIdentifying persons with diabetes using Medicare claims data.Design and methods for a randomized clinical trial of a diabetes self-management intervention for low-income Latinos: Latinos en Control.Temporal data mining for the assessment of the costs related to diabetes mellitus pharmacological treatment.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban ChinaEstimating the Cost of Illness of Giant Cell Arteritis in the United States.Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trialWithin-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.Diabetic patients who smoke: are they different?Impact of an electronic medical record on diabetes quality of careThe use of computerized birthday greeting reminders in the management of diabetes.Diabetes trends in the USA.Diabetes performance measures: current status and future directions.An overview of management issues in adult patients with type 2 diabetes mellitus.A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: study protocol (NCT00362193).Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists.Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus.The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetesSelecting an A1C Point-of-Care InstrumentHealthcare costs around the time of smoking cessation.Epidemiology, costs, consequences, and pathophysiology of type 2 diabetes: an american epidemicAre characteristics of the medical home associated with diabetes care costs?Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one yearBlood pressure control among patients with hypertension and newly diagnosed diabetes.Community-based physical activity interventions for treatment of type 2 diabetes: a systematic review with meta-analysisHealth care costs in people with diabetes and their association with glycemic control and kidney function.Effect of hospital admission on glycemic control 1 year after dischargeClinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications.Glycemic control in young children with diabetes: the role of parental health literacy.Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs.Design features of the Diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabeThe business of intensive insulin therapy for type 2 diabetes patients: where it all began for me.
P2860
Q24797542-A2A5B03C-8906-4825-9D97-CB68B93E89C2Q25255574-4F91D80D-8008-428D-AD47-C1D70E3CFE3DQ25257447-11A8754D-C2B4-407A-90EB-043E804BCCF1Q26829072-30A44D32-EF53-4681-9FA8-CF9F26534DF0Q28192612-280CFBD4-44C0-453F-926B-88E0A2E31E0FQ28193521-62350FA8-7415-4A3C-BAD0-C298117AB618Q31443172-F91AE3FC-B87F-4A5C-B94A-4D1756654B66Q33517854-09F3CBAA-C88C-4BD0-A4E9-2FCFCB707620Q33547379-CE3ED232-6050-421C-B14C-67BDA725E4F3Q33652884-041FB69B-5583-40D5-A086-65D24AAE9667Q33667465-280D05BB-8610-44C3-B343-ABBDA76A080CQ33725515-AD3AFB19-17F4-4AC9-808A-64E7A4CC0809Q34032663-2D50AC0B-1351-4C77-A3AA-B223AA0F6233Q34335538-83CA04EB-BE21-4A78-8157-4EF6BF39A18FQ34628302-0E938816-7571-4BF8-B134-A2A85CCB88B0Q34629410-D87EB12D-8C11-4A2D-B684-A638B70F3014Q34743143-79979DE1-2B69-4820-90D9-CE0A5A0152EAQ34906314-7628E0CE-2C2C-4272-A534-261C431471A4Q35060223-91A11EAB-7551-440C-A776-04C89BA5D63CQ35075959-54720DE9-8612-40DA-AC48-2BD59BAA7353Q35126915-CE0F1F34-397B-4A9D-99C1-273010E5796BQ35151533-0560D5D5-0E3F-46E8-8E38-993CF05468A8Q35800964-215FBDF1-7A7E-46A1-8E8B-606D62C57959Q35841138-FB58EBBC-AD8C-4A84-8A02-7583D3B77563Q35876380-8D7E4D8C-DA5A-48B7-AD01-F308E7B74024Q35953862-EF8392F3-F319-4563-9748-CC5C857E610AQ35982121-C50402C2-D5BF-471C-AF66-2C567582A1D8Q36065461-CB4F70B3-B55F-4D3A-894E-4A09D02D3752Q36270263-A1A9FD12-C713-4EC2-9FE0-F0483A81E8B9Q36341165-A082976F-2C0C-479E-9B0E-78ADA179F76FQ36351670-340D9A12-D5DD-4547-8084-806064C71136Q36568834-9FE2CF4E-8DE5-437F-B49E-7CBDFEE86219Q36782623-A89E6A1E-4C3F-4E3D-9151-D37B1846AE3FQ37102984-D7E4A899-3A06-466A-9737-99579B127F9CQ37193496-C788B50F-D454-4F2A-9EBA-35ADA9448B84Q37313678-359188AA-AA76-4688-AC44-A885E924A4D9Q37396959-FB3D233D-BDB2-49F1-908A-5AE15631BAEBQ37417227-E846C6E2-83C6-41D8-90EA-BE18B41CDAB4Q37451703-E7362666-C73A-4DF4-BE72-DE4ED781A662Q37453178-19FECEE1-6C48-4EA1-AE93-ABC1E7AE4D0C
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The cost to health plans of poor glycemic control.
@en
type
label
The cost to health plans of poor glycemic control.
@en
prefLabel
The cost to health plans of poor glycemic control.
@en
P2093
P1433
P1476
The cost to health plans of poor glycemic control.
@en
P2093
P304
P356
10.2337/DIACARE.20.12.1847
P407
P577
1997-12-01T00:00:00Z